China Precision Steel Inc (NASDAQ:CPSL) announced its fiscal year 2014 Q3 results for the period ended March 31st 2014. Revenue for the Q3 of fiscal year 2014 was USD 14.2 million, up 66.3% from revenue of USD 8.6 million in the Q3 of fiscal year 2013. The increase in revenue was mainly attributable to increased marketing and sales in the domestic market. China Precision Steel, Inc. (NASDAQ:CPSL) stock performance was -7.50% in last session and finished the day at $1.70. Traded volume was 19,411.00million shares in the last session and the average volume of the stock remained 62.18K shares. The beta of the stock remained 2.16. China Precision Steel, Inc. (NASDAQ:CPSL) insider ownership is 33.39%.

Valhi, Inc (NYSE:VHI) announced a quarterly dividend on Tuesday, May 13th, StockRatingsNetwork reports. Investors of record on Monday, June 9th will be paid a dividend of 0.02 per share on Thursday, June 26th. This represents a $0.08 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Thursday, June 5th. The Company last posted its quarterly earnings results on Friday, March 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. Analysts expect that Valhi will post $0.10 EPS for the current fiscal year. Valhi, Inc. (NYSE:VHI) dropped -5.74 percent to $6.57 Monday on volume of 68,440.00million shares. The intra-day range of the stock was $6.55 to $7.01. Valhi, Inc. (NYSE:VHI) has a market capitalization of $2.23billion.

In addition to IBM’s research, Metabolix Inc. (NASDAQ:MBLX) and other companies are exploring whether plants can be genetically engineered to make polymers for producing bioplastics in a way that’s cheaper than oil-based plastics. Metabolix, Inc. (NASDAQ:MBLX)’s stock on May 19, 2014 reported a decrease of -5.94% to the closing price of $0.950. Its fifty two weeks range is $0.75 -$2.10. The total market capitalization recorded $33.14million. The overall volume in the last trading session was 76,263.00million shares. In its share capital, MBLX has 34.95million outstanding shares.

Marrone Bio Innovations, Inc. (NASDAQ:MBII) 8.9% LOWER; announced that it has filed a registration statement with the Securities and Exchange Commission for a public offering of up to $35 million of common stock to be sold by MBI and selling stockholders, including shares MBI may sell to the underwriters under a 30-day option to purchase additional shares. On Monday, shares of Marrone Bio Innovations Inc (NASDAQ:MBII) dropped -5.78% to close the day at $8.80. Company return on investment (ROI) is -51.10% and its monthly performance is recorded as -26.48%. Marrone Bio Innovations Inc (NASDAQ:MBII) quarterly revenue growth is -38.50%.